Apixaban for the Acute Treatment of Venous Thromboembolism in Children
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 150
Summary
- Conditions
- Venous Thromboembolism
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 17 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02464969
- Collaborators
- Bristol-Myers Squibb
- Investigators
- Study Director: Pfizer CT.gov Call Center Pfizer
Get Well Soon